Results 131 to 140 of about 36,454,286 (290)

L-NAME improves BCG-induced proliferation.

open access: yes, 2013
NIH-3T3 fibroblast were treated with BCG (3×106 CFU/ml), L-NAME (2 mM) or BCG and L-NAME in presence of LY 294002 and PD 98059 for 24 and 48 h respectively. Cell viability was evaluated by MTS.
Yanina Langle (360584)   +7 more
core   +1 more source

Salmonella lipopolysaccharide‐containing supported lipid bilayers as platforms to study bacteriophage interactions

open access: yesFEBS Letters, EarlyView.
We present robust protocols for the preparation of supported lipid bilayers (SLBs) incorporating either Salmonella smooth LPS or outer membrane vesicles (OMVs). We use a combination of quartz crystal microbalance with dissipation (QCM‐D) and fluorescence microscopy to both characterize the SLBs of various compositions and to probe their interactions ...
Hudson P. Pace   +6 more
wiley   +1 more source

Microbiome−host proteostasis crosstalk—An emerging perspective on mechanisms and interventions toward healthy longevity

open access: yesFEBS Letters, EarlyView.
Proteostasis and the gut microbiota play a key role in shaping host physiology. Microbiota‐derived metabolites, vitamins, and RNA modulate host proteostasis. Findings from model systems, including C. elegans, indicate microbes can either stabilize or disrupt host proteostasis.
Abhishek Anil Dubey, Maria Ermolaeva
wiley   +1 more source

Design and analysis strategies for robust microbiome ageing research

open access: yesFEBS Letters, EarlyView.
The gut microbiome changes with age and associates with age‐related morbidity and mortality, establishing it as a potential biomarker and intervention target for ageing. Realising this potential requires methodological rigour, yet distinguishing biological signals from methodological artefacts remains challenging across cohorts. This review provides an
Mark Olenik   +5 more
wiley   +1 more source

ENHANCED FOOD INTAKE SUPPRESSION AND BODY MASS REDUCTION WITH COMBINED L-NAME AND LEPTIN ADMINISTRATION IN FASTED RATS

open access: yesTrakia Journal of Sciences
PURPOSE: This study aimed to investigate the effect of combining Nω-Nitro-L-argininemethyl ester (L-NAME) and leptin on food intake and body mass gain in fasted rats, as both have been shown to suppress food consumption.
M.Hristov
doaj   +1 more source

[Stammbuch Emilie Scheitz [Früherer Name: Emilie Grimm]] / L. Hess [PDF]

open access: yes
[STAMMBUCH EMILIE SCHEITZ [FRÜHERER NAME: EMILIE GRIMM]] / L. HESS [Stammbuch Emilie Scheitz [Früherer Name: Emilie Grimm]] / L. Hess (1) Cover (1) Einträge und Illustrationen Bl. 1 - 20 (16) Einträge und Illustrationen Bl.
Scheitz, Emilie
core  

ABL kinase‐dependent phosphorylation of SH proteins promotes their direct interaction with CRK family SH2 domains

open access: yesFEBS Letters, EarlyView.
CT10 regulator of kinase (CRK) and CRK‐Like (CRKL) are signaling adaptors driving cell adhesion, motility, differentiation, and proliferation. SH2‐domain containing (SH) proteins are enriched in YXXP motifs which when phosphorylated create preferred binding sites for CRK family SH2 domains.
Phoebe M. Cousens   +8 more
wiley   +1 more source

Reconstructing enzyme evolution by protein engineering

open access: yesFEBS Letters, EarlyView.
Natural enzyme evolution can be retraced by protein engineering methods such as directed evolution, rational design, and ancestral sequence reconstruction. These approaches reveal how enzymes emerged from ligand‐binding scaffolds, developed varying substrate preferences, formed oligomeric complexes, adapted to environmental changes, and evolved novel ...
Lukas Drexler   +2 more
wiley   +1 more source

Investigating transcription factor dynamics in health and disease using FRAP

open access: yesFEBS Letters, EarlyView.
FRAP analysis of GFP‐tagged transcription factors reveals how molecular mobility and target engagement change in response to drug treatment. By combining live‐cell imaging, quantitative model fitting, and statistical analysis, this approach uncovers transcription factor dynamics linked to disease mechanisms, providing a powerful framework for ...
Kannan Govindaraj   +3 more
wiley   +1 more source

Cardiac hypertrophy and fibrosis in chronic L-NAME-treated AT2 receptor-deficient mice

open access: yes, 2004
Background: The role of angiotensin II type 1 (AT1) and type 2 (AT2) receptors in cardiac hypertrophy and fibrosis is incompletely understood. The availability of AT2 receptor-deficient mice (AT 2 -/y) makes it possible to study the effects of AT1 ...
Groene, H.J.   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy